Page 18 - Pharma Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. RAMM Pharma Commences Sales of NettaPet™ CBD Enriched Super Premium Quality Dog Food with ... RAMM Pharma Corp.April 9, 2021 GMT TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) (OTC: RAMMF), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has commenced commercial sales of its NettaPet™ cannabidiol (“CBD”) enriched super premium quality dog food. N...

COVID-19 Vaccination Syringes Prepared & Distributed by RAMM Pharma TORONTO — RAMM Pharma Corp., a cannabinoid pharmaceutical products company, announces that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has selected RAMM as a fulfilment and distribution partner for Uruguay’s COVID-19 vaccination program. Under the arrangement, RAMM will be responsible for the sterilization, packaging and distribution of syringes and other medical supplies for use in the country’s COVID-19 vaccination program. RAMM’s GMP certified pharmaceutical facility was sel...

ADVANZ Pharma Corp. Limited - Update on Formal Sale Process PR Newswire London, January 21 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE 21 January 2021 Update on Formal Sale Process

Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing January 20, 2021 09:48 ET | Source: Canapar Corp. Canapar Corp. Toronto, Ontario, CANADA RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, "RAMM") (CSE: RAMM) are pleased to announce they have entered into a strategic partnership, combining Canapar’s hemp-derived cannabidiol (CBD) extraction expertise with RAMM’s leadership in cannabis-derived pharmaceutical and cosmeceu...

About the European Cannabis Market Europe represents one of the largest potential cannabis markets globally. The Europe cannabis market is currently valued at US$3.5 billion and expected to reach US$37 billion by 2027 with an anticipated CAGR of 29.6% from 2020 to 2027 (ResearchAndMarkets.com, 2020). European countries are experiencing a transformation in the regulations for marketing cannabis and related products, facilitating easier cultivation, processing, and trade of the cannabis-derived products across this region. Terms of the Transaction The Canapar Shares were acquired for C$7,000,00...